# Ming Bioventures

Ming Bioventures is a Venture Capital based in Suzhou, China.

## Overview

- **Organization type:** Venture Capital
- **Headquarters:** Suzhou, China
- **Region:** Asia
- **Address:** Suzhou, China
- **Founded:** 2018
- **Assets under management:** Undisclosed
- **Website:** www.mingbioventures.com

## Regulatory record

- **Reports private funds:** No

## About

Ming Bioventures is a private equity firm based in Suzhou, China. It focuses on venture capital investments. The firm manages approximately $308.66 million in assets, with $44.75 million in available capital.

## Sectors

- Digital Health
- AI/ML
- Biotechnology & Life Sciences

## Questions

### What investment stages does Ming Bioventures target?

The firm focuses on early-stage life sciences investments, specifically seed rounds and start-up formation. It enters at the point of pre-clinical validation or first-in-human data, reflecting the translational science model prevalent in China's biotech cluster strategy. Follow-on participation beyond Series A has not been disclosed publicly.

### Is Ming Bioventures structured as a venture capital firm or does it operate more like a growth equity manager?

Ming Bioventures operates as a traditional venture capital firm with a concentration at the earliest stages of drug development. Its seed and start-up focus places it before the growth-equity inflection point where assets have de-risked clinical milestones. The firm's structure — absent any public buyout or crossover activity — aligns with the preclinical venture model common among China's biotech-dedicated managers tracking assets from bench to first regulatory filing.

### How is Ming Bioventures connected to the broader Suzhou BioBay ecosystem?

The firm is headquartered in Suzhou BioBay, a state-backed biotech park that houses over 500 life sciences companies, Cold Spring Harbor Asia, and several premier Chinese genomic sequencing enterprises. For an early-stage investor, physical proximity to this tenant base functions as both origination infrastructure and a surveillance mechanism for licensing ready assets. Ming Bioventures' specific institutional ties to BioBay's government operator or to on-site accelerators have not been disclosed.

## Related profiles

- [Minetta Investments](https://altss.com/profile/minetta-investments)
- [Mingde Boya Investment Management](https://altss.com/profile/mingde-boya-investment-management)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/ming-bioventures

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology